Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Changi General Hospital
This is an open-label study, with 4 scheduled visits. Recruitment of 100 subjects. Assessments include demographics, diagnosis, smoking frequency, Clinical Global Scale (CGI-S), weight, height,blood pressure, waist and hip circumference and fasting blood glucose and lipd profile.
Statistical analysis will be exploratory and mainly descriptive.
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Give informed consent
Requires pharmacological treatment with escitalopram for major depression, generalized anxiety disorder or panic disorder
Aged 21 years old and above
Able to comprehend and comply with protocol
Not pregnant and if of child-bearing age, using adequate methods of contraception
You may not be if
Currently taking or has taken in previous 3 months, any other antidepressants, antipsychotics, mood stabilizers, weight loss or lipid-profile modifying drugs
Contraindications to escitalopram
Unstable medical illness and/or is already under treatment of diabetes, hypertension, dyslipidemia, ischemic heart disease
History of non-response to escitalopram
Meets IDF definition of metabolic syndrome
Significant risk of suicide
Primary diagnosis or comorbid diagnosis of psychotic disorder, bipolar disorder, substance dependence and/or dementia